Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
Need2Know: February 10, 2023
The death toll in the Turkey Syria earthquake has passed 21,000, Minnesota Rep. Angie Craig was attacked, and shots to stop bird flu. Here is everything you Need2Know for Friday, February 10, 2023.
Load More